Comments

AN2 Therapeutics

ANTXNASDAQ
Logo brought to you by Benzinga Data
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$1.05
-0.03-2.78%
At Close: -
$1.08
0.032.86%
After Hours: Sep 20, 4:51 PM EDT
15 minutes delayed
AN2 Therapeutics (ANTX) ForecastNewsEarnings

Guidance

DividendsAnalyst RatingsInsider TradesShort Interest

AN2 Therapeutics (NASDAQ:ANTX) Stock, Guidance And Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

Data brought to you by Benzinga APIs

FAQ

Q

What is the most recent guidance for AN2 Therapeutics (ANTX)?

A

There have been no specific sales or earnings guidance reported for AN2 Therapeutics in recent months.

Browse guidance and forecast on all stocks.

People Also Watch